iqvia semaglutide tirzepatide prescriptions us q3 2024 Trends in GLP-1 medication switching Impact of the CVS GLP-1

Prescription weight loss injections should never be approached casually, especially when long-term health and metabolic function are involved

It potentially halts a disease trajectory

This allows the product to be supplied in multi-dose vials and used for repeated withdrawals, in contrast to preservative-free sterile water which is intended for single use only

Tirzepatide is a once-weekly injectable medication approved for type 2 diabetes and chronic weight management, offering patients flexibility in administration timing

This level of weight loss is comparable to outcomes seen with certain bariatric surgerieswithout the need for invasive procedures

Shelf life after opening: 28 days when stored at room temperature or refrigerated